255 related articles for article (PubMed ID: 31822494)
1. Extracellular ATP and Purinergic P2Y
Schulien I; Hockenjos B; van Marck V; Ayata CK; Follo M; Thimme R; Hasselblatt P
Cancer Res; 2020 Feb; 80(4):699-708. PubMed ID: 31822494
[TBL] [Abstract][Full Text] [Related]
2. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
3. The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP.
Xie R; Xu J; Wen G; Jin H; Liu X; Yang Y; Ji B; Jiang Y; Song P; Dong H; Tuo B
J Biol Chem; 2014 Jul; 289(27):19137-49. PubMed ID: 24847054
[TBL] [Abstract][Full Text] [Related]
4. Activation of the P2Y
Orriss IR; Guneri D; Hajjawi MOR; Shaw K; Patel JJ; Arnett TR
J Endocrinol; 2017 Jun; 233(3):341-356. PubMed ID: 28420708
[TBL] [Abstract][Full Text] [Related]
5. P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy.
Tackett BC; Sun H; Mei Y; Maynard JP; Cheruvu S; Mani A; Hernandez-Garcia A; Vigneswaran N; Karpen SJ; Thevananther S
Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(11):G1073-87. PubMed ID: 25301185
[TBL] [Abstract][Full Text] [Related]
6. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
7. P2Y
Khalafalla FG; Greene S; Khan H; Ilves K; Monsanto MM; Alvarez R; Chavarria M; Nguyen J; Norman B; Dembitsky WP; Sussman MA
Circ Res; 2017 Nov; 121(11):1224-1236. PubMed ID: 28923792
[TBL] [Abstract][Full Text] [Related]
8. The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease.
Müller T; Fay S; Vieira RP; Karmouty-Quintana H; Cicko S; Ayata K; Zissel G; Goldmann T; Lungarella G; Ferrari D; Di Virgilio F; Robaye B; Boeynaems JM; Blackburn MR; Idzko M
Oncotarget; 2017 May; 8(22):35962-35972. PubMed ID: 28415591
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks.
Helms TH; Mullins RD; Thomas-Ahner JM; Kulp SK; Campbell MJ; Lucas F; Schmidt N; LeMoine DM; Getaneh S; Xie Z; Phelps MA; Clinton SK; Coss CC
Sci Rep; 2021 Feb; 11(1):3646. PubMed ID: 33574348
[TBL] [Abstract][Full Text] [Related]
10. Increased Purinergic Responses Dependent on P2Y2 Receptors in Hepatocytes from CCl
Velázquez-Miranda E; Molina-Aguilar C; González-Gallardo A; Vázquez-Martínez O; Díaz-Muñoz M; Vázquez-Cuevas FG
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225112
[TBL] [Abstract][Full Text] [Related]
11. Extracellular ATP activates c-jun N-terminal kinase signaling and cell cycle progression in hepatocytes.
Thevananther S; Sun H; Li D; Arjunan V; Awad SS; Wyllie S; Zimmerman TL; Goss JA; Karpen SJ
Hepatology; 2004 Feb; 39(2):393-402. PubMed ID: 14767992
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation.
Liu ZN; Jia WQ; Jiang T; Dai JW; Shuai C; Lv XW
Int Immunopharmacol; 2019 Dec; 77():105915. PubMed ID: 31639617
[TBL] [Abstract][Full Text] [Related]
13. P2Y
Jin H; Ko YS; Park SW; Kim HJ
Free Radic Biol Med; 2019 May; 136():109-117. PubMed ID: 30959169
[TBL] [Abstract][Full Text] [Related]
14. P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer.
Jin H; Ko YS; Kim HJ
Int J Oncol; 2018 Nov; 53(5):1953-1966. PubMed ID: 30226596
[TBL] [Abstract][Full Text] [Related]
15. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
[TBL] [Abstract][Full Text] [Related]
16. P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells.
Jin H; Eun SY; Lee JS; Park SW; Lee JH; Chang KC; Kim HJ
Breast Cancer Res; 2014 Aug; 16(5):R77. PubMed ID: 25156554
[TBL] [Abstract][Full Text] [Related]
17. Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury.
Lin YH; Zhang S; Zhu M; Lu T; Chen K; Wen Z; Wang S; Xiao G; Luo D; Jia Y; Li L; MacConmara M; Hoshida Y; Singal AG; Yopp A; Wang T; Zhu H
Gastroenterology; 2020 May; 158(6):1698-1712.e14. PubMed ID: 31972235
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.
Martinez NA; Ayala AM; Martinez M; Martinez-Rivera FJ; Miranda JD; Silva WI
J Biol Chem; 2016 Jun; 291(23):12208-22. PubMed ID: 27129210
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
20. The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.
Sheppard S; Guedes J; Mroz A; Zavitsanou AM; Kudo H; Rothery SM; Angelopoulos P; Goldin R; Guerra N
Nat Commun; 2017 Jan; 8():13930. PubMed ID: 28128200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]